Analyzing Eli Lilly's drug pipeline

Eli Lilly CEO: We're growing based on the back of our newest pharma products

Eli Lilly looking for smaller acquisitions: CEO

Eli Lilly goes direct-to-consumer on weight loss drugs: What patients and investors need to know

Eli Lilly CEO: We know there's high demand for weight-loss drugs and we're ready to meet it

Jim Cramer: Eli Lilly stock represents real value

Eli Lilly stock tumbles 10% after drug giant misses estimates and slashes profit guidance

Eli Lilly CEO weighs in on Q4 revenue miss